Prelude Therapeutics Statistics
Total Valuation
PRLD has a market cap or net worth of $58.86 million. The enterprise value is $5.26 million.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PRLD has 56.60 million shares outstanding. The number of shares has increased by 5.12% in one year.
| Current Share Class | 43.75M |
| Shares Outstanding | 56.60M |
| Shares Change (YoY) | +5.12% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 7.86% |
| Owned by Institutions (%) | 11.93% |
| Float | 29.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.58 |
| Forward PS | n/a |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.24.
| Current Ratio | 3.68 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -96.33% and return on invested capital (ROIC) is -57.36%.
| Return on Equity (ROE) | -96.33% |
| Return on Assets (ROA) | -49.75% |
| Return on Invested Capital (ROIC) | -57.36% |
| Return on Capital Employed (ROCE) | -143.61% |
| Revenue Per Employee | $53,435 |
| Profits Per Employee | -$948,992 |
| Employee Count | 131 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.00% in the last 52 weeks. The beta is 1.24, so PRLD's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -60.00% |
| 50-Day Moving Average | 0.99 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 45.61 |
| Average Volume (20 Days) | 233,807 |
Short Selling Information
The latest short interest is 531,205, so 0.94% of the outstanding shares have been sold short.
| Short Interest | 531,205 |
| Short Previous Month | 510,202 |
| Short % of Shares Out | 0.94% |
| Short % of Float | 1.82% |
| Short Ratio (days to cover) | 2.55 |
Income Statement
In the last 12 months, PRLD had revenue of $7.00 million and -$124.32 million in losses. Loss per share was -$1.64.
| Revenue | 7.00M |
| Gross Profit | 7.00M |
| Operating Income | -135.01M |
| Pretax Income | -129.85M |
| Net Income | -124.32M |
| EBITDA | -133.25M |
| EBIT | -135.01M |
| Loss Per Share | -$1.64 |
Full Income StatementBalance Sheet
The company has $73.22 million in cash and $17.92 million in debt, giving a net cash position of $55.30 million or $0.98 per share.
| Cash & Cash Equivalents | 73.22M |
| Total Debt | 17.92M |
| Net Cash | 55.30M |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 75.84M |
| Book Value Per Share | 1.34 |
| Working Capital | 55.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$108.35 million and capital expenditures -$183,000, giving a free cash flow of -$108.53 million.
| Operating Cash Flow | -108.35M |
| Capital Expenditures | -183,000 |
| Free Cash Flow | -108.53M |
| FCF Per Share | -$1.92 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,928.67% |
| Pretax Margin | -1,775.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRLD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.12% |
| Shareholder Yield | -5.12% |
| Earnings Yield | -205.27% |
| FCF Yield | -179.20% |
Analyst Forecast
The average price target for PRLD is $4.00, which is 284.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 284.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 26.62% |
| EPS Growth Forecast (5Y) | -11.76% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRLD has an Altman Z-Score of -9.45 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.45 |
| Piotroski F-Score | 1 |
